-
SICEM 2025
SICEM 2025
- Program
- Abstracts
-
Participation
Participation
- Venue
-
News & Gallery
News & Gallery
LOG IN
SIGN UP
KESScientific program
Joint symposium
-
AFES-ESROC-KES joint symposium. Advances in thyroid disease
Day 2, Friday, May 2, 14:00-15:30 / Room 2 (B2)
Overview
-
The AFES-ESROC-KES Joint Symposium focuses on the latest advancements in thyroid disease, bringing together experts from the ASEAN Federation of Endocrine Societies (AFES), the Endocrine Society of the Republic of China (ESROC), and the Korean Endocrine Society (KES). This symposium serves as a platform for discussing cutting-edge research, clinical innovations, and regional perspectives on thyroid disorders. Through expert presentations and in-depth discussions, the symposium aims to enhance collaboration, drive scientific progress, and improve patient care in the field of thyroid disease.
Chairpersons: Tran Huu Dang (Hue University, Vietnam), Feng-Hsuan Liu (Chang Gung University, Taiwan)
*AFES: ASEAN Federation of Endocrine Societies
*ESROC: The Endocrine Society of the
Republic of China (Taiwan)
14:00-14:25
Epigenetic regulation in thyroid cancer: an overlooked player beyond genetic mutations
Feng-Chih Kuo (Tri-Service General Hospital, Taiwan)
14:25-14:50
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in NSCLC
Tae Hyuk Kim (Sungkyunkwan University, Korea)
14:50-15:15
Moving forward in th(AI)roid cancer: exploring the role of artificial intelligence in diagnosis and management
Sjoberg Kho (University of Santo Tomas Hospital, Philippines)
Discussion
15:15-15:30
-
ESA-KES joint symposium. Anti-resorptive agents: dispelling myths and revealing truths
Day 2, Friday, May 2, 16:50-18:20 / Room 3 (1F)
Overview
-
The ESA-KES joint symposium will address misconceptions about anti-resorptive agents and discuss practical treatment strategies. Professor Christian Girgis will present insights on denosumab discontinuation, Professor Sung Hye Kong will examine its necessity in dental procedures, and Professor Hanh Nguyen will discuss managing atypical femur fractures. This session will provide key updates and clinical insights on osteoporosis treatment.
Chairpersons : Shane Hamblin (Monash University, Australia), Eun Gyoung Hong (Hallym University, Korea)
*ESA: Endocrine Society of Autralia
16:50-17:15
Denosumab discontinuation in 2025: new insights, potential solutions
Christian Girgis (University of Sydney, Australia)
17:15-17:40
Fact or fiction: the necessity of stopping anti-resorptives in dental procedures
Sung Hye Kong (Seoul National University, Korea)
17:40-18:05
Atypical femur fractures – current insights and best practice management
Hanh Nguyen (Monash University, Australia)
Discussion
18:05-18:20
-
ES-KES joint symposium. Facing the challenges of diabetes: research, prevention, and precision medicine
Day 3, Saturday, May 3, 08:30-10:00 / Room 1 (B2)
Overview
-
Aligned with SICEM 2025's theme, "Facing the Challenges," this ES-KES joint symposium explores the growing burden of diabetes. Professor William Cefalu will discuss the role of biomedical research, while Professor William Herman examines the cost-effectiveness of diabetes prevention. Professor Soo Heon Kwak will highlight the challenges and opportunities of genetic information in precision medicine. This session will provide key insights for advancing diabetes management and prevention.
Chairpersons : William T. Cefalu (National Institutes of Health, NIDDK, USA), Sung Hee Choi (Seoul National University, Korea)
*ES: Endocrine Society
08:30-09:00
The growing burden of diabetes and the role of biomedical research
William T. Cefalu (National Institutes of Health, NIDDK, USA)
09:00-09:30
The cost-effectiveness of diabetes prevention
William Herman (University of Michigan, USA)
09:30-10:00
Genetic information in clinic: challenges and opportunities for precision medicine
Soo Heon Kwak (Seoul National University, Korea)
-
ESE-KES joint symposium. Glucocorticoid-induced adrenal insufficiency
Day 3, Saturday, May 3, 11:20-12:50 / Room 2 (B2)
Overview
-
The ESE-KES Joint Symposium aims to foster mutual friendship and collaboration between two societies. This year’s symposium will focus on Glucocorticoid-Induced Adrenal Insufficiency, featuring two expert speakers from ESE (Eystein Husebye and Alessandro Prete) who will present the latest updates from newly published guidelines. This year’s symposium will be conducted in an interactive format with live Q&A sessions to enhance engagement and discussion. Additionally, Mi Kyung Kim from KES will share insights on the Korean status and data related to this condition. This session promises to provide valuable knowledge and diverse perspectives to enhance clinical practice.
Chairpersons : Martin Reincke (University Hospital Munich, Germany), Man Ho Choi (KIST, Korea)
*ESE: European Society of Endocrinology
11:20-12:20
(Interactive format with live Q&A)
ESE-ES Joint Clinical Practice Guideline on Diagnosis and Therapy of Glucocorticoid-Induced Adrenal Insufficiency
Eystein Husebye
(University of Bergen, Norway)
Alessandro Prete
(University of Birmingham, UK)
12:20-12:50
Glucocorticoid-induced adrenal insufficiency: the Korean clinical experience
Mi Kyung Kim (Keimyung University, Korea)
- AFES-ESROC-KES joint symposium. Advances in thyroid disease Day 2, Friday, May 2, 14:00-15:30 / Room 2 (B2) Overview
-
The AFES-ESROC-KES Joint Symposium focuses on the latest advancements in thyroid disease, bringing together experts from the ASEAN Federation of Endocrine Societies (AFES), the Endocrine Society of the Republic of China (ESROC), and the Korean Endocrine Society (KES). This symposium serves as a platform for discussing cutting-edge research, clinical innovations, and regional perspectives on thyroid disorders. Through expert presentations and in-depth discussions, the symposium aims to enhance collaboration, drive scientific progress, and improve patient care in the field of thyroid disease.
Chairpersons: Tran Huu Dang (Hue University, Vietnam), Feng-Hsuan Liu (Chang Gung University, Taiwan)
*AFES: ASEAN Federation of Endocrine Societies
*ESROC: The Endocrine Society of the
Republic of China (Taiwan)
*ESROC: The Endocrine Society of the
Republic of China (Taiwan)
|
|
14:00-14:25 | Epigenetic regulation in thyroid cancer: an overlooked player beyond genetic mutations Feng-Chih Kuo (Tri-Service General Hospital, Taiwan) |
|
|
14:25-14:50 | Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in NSCLC Tae Hyuk Kim (Sungkyunkwan University, Korea) |
|
|
14:50-15:15 | Moving forward in th(AI)roid cancer: exploring the role of artificial intelligence in diagnosis and management Sjoberg Kho (University of Santo Tomas Hospital, Philippines) |
| Discussion | ||
|---|---|---|
| 15:15-15:30 | ||
- ESA-KES joint symposium. Anti-resorptive agents: dispelling myths and revealing truths Day 2, Friday, May 2, 16:50-18:20 / Room 3 (1F) Overview
-
The ESA-KES joint symposium will address misconceptions about anti-resorptive agents and discuss practical treatment strategies. Professor Christian Girgis will present insights on denosumab discontinuation, Professor Sung Hye Kong will examine its necessity in dental procedures, and Professor Hanh Nguyen will discuss managing atypical femur fractures. This session will provide key updates and clinical insights on osteoporosis treatment.
Chairpersons : Shane Hamblin (Monash University, Australia), Eun Gyoung Hong (Hallym University, Korea)
*ESA: Endocrine Society of Autralia
|
|
16:50-17:15 | Denosumab discontinuation in 2025: new insights, potential solutions Christian Girgis (University of Sydney, Australia) |
|
|
17:15-17:40 | Fact or fiction: the necessity of stopping anti-resorptives in dental procedures Sung Hye Kong (Seoul National University, Korea) |
|
|
17:40-18:05 | Atypical femur fractures – current insights and best practice management Hanh Nguyen (Monash University, Australia) |
| Discussion | ||
|---|---|---|
| 18:05-18:20 | ||
- ES-KES joint symposium. Facing the challenges of diabetes: research, prevention, and precision medicine Day 3, Saturday, May 3, 08:30-10:00 / Room 1 (B2) Overview
-
Aligned with SICEM 2025's theme, "Facing the Challenges," this ES-KES joint symposium explores the growing burden of diabetes. Professor William Cefalu will discuss the role of biomedical research, while Professor William Herman examines the cost-effectiveness of diabetes prevention. Professor Soo Heon Kwak will highlight the challenges and opportunities of genetic information in precision medicine. This session will provide key insights for advancing diabetes management and prevention.
Chairpersons : William T. Cefalu (National Institutes of Health, NIDDK, USA), Sung Hee Choi (Seoul National University, Korea)
*ES: Endocrine Society
|
|
08:30-09:00 | The growing burden of diabetes and the role of biomedical research William T. Cefalu (National Institutes of Health, NIDDK, USA) |
|
|
09:00-09:30 | The cost-effectiveness of diabetes prevention William Herman (University of Michigan, USA) |
|
|
09:30-10:00 | Genetic information in clinic: challenges and opportunities for precision medicine Soo Heon Kwak (Seoul National University, Korea) |
- ESE-KES joint symposium. Glucocorticoid-induced adrenal insufficiency Day 3, Saturday, May 3, 11:20-12:50 / Room 2 (B2) Overview
-
The ESE-KES Joint Symposium aims to foster mutual friendship and collaboration between two societies. This year’s symposium will focus on Glucocorticoid-Induced Adrenal Insufficiency, featuring two expert speakers from ESE (Eystein Husebye and Alessandro Prete) who will present the latest updates from newly published guidelines. This year’s symposium will be conducted in an interactive format with live Q&A sessions to enhance engagement and discussion. Additionally, Mi Kyung Kim from KES will share insights on the Korean status and data related to this condition. This session promises to provide valuable knowledge and diverse perspectives to enhance clinical practice.
Chairpersons : Martin Reincke (University Hospital Munich, Germany), Man Ho Choi (KIST, Korea)
*ESE: European Society of Endocrinology
|
|
11:20-12:20 |
(Interactive format with live Q&A) ESE-ES Joint Clinical Practice Guideline on Diagnosis and Therapy of Glucocorticoid-Induced Adrenal Insufficiency |
Eystein Husebye (University of Bergen, Norway) |
|
|
Alessandro Prete (University of Birmingham, UK) |
||
|
|
12:20-12:50 | Glucocorticoid-induced adrenal insufficiency: the Korean clinical experience Mi Kyung Kim (Keimyung University, Korea) | |